These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 29059230

  • 1. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
    Wu NC, Zost SJ, Thompson AJ, Oyen D, Nycholat CM, McBride R, Paulson JC, Hensley SE, Wilson IA.
    PLoS Pathog; 2017 Oct; 13(10):e1006682. PubMed ID: 29059230
    [Abstract] [Full Text] [Related]

  • 2. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
    Wu NC, Lv H, Thompson AJ, Wu DC, Ng WWS, Kadam RU, Lin CW, Nycholat CM, McBride R, Liang W, Paulson JC, Mok CKP, Wilson IA.
    Cell Host Microbe; 2019 Jun 12; 25(6):836-844.e5. PubMed ID: 31151913
    [Abstract] [Full Text] [Related]

  • 3. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE.
    Proc Natl Acad Sci U S A; 2017 Nov 21; 114(47):12578-12583. PubMed ID: 29109276
    [Abstract] [Full Text] [Related]

  • 4. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T, Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Takahashi H, Suzuki N, Kawaoka Y, Watanabe S, Odagiri T.
    Jpn J Infect Dis; 2018 May 24; 71(3):234-238. PubMed ID: 29709975
    [Abstract] [Full Text] [Related]

  • 5. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM, Alefantis T, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978710
    [Abstract] [Full Text] [Related]

  • 6. Influenza H3N2 Vaccines: Recent Challenges.
    Mostafa A, Pleschka S.
    Trends Microbiol; 2018 Feb 15; 26(2):87-89. PubMed ID: 29268980
    [Abstract] [Full Text] [Related]

  • 7. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L, Wharton SA, Martin SR, Cross K, Lin Y, Liu Y, Feizi T, Daniels RS, McCauley JW.
    J Gen Virol; 2016 Jun 15; 97(6):1333-1344. PubMed ID: 26974849
    [Abstract] [Full Text] [Related]

  • 8. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429350
    [Abstract] [Full Text] [Related]

  • 9. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR, Cheng CY, Chen CY, Lin CH, Kuo CY, Huang HY, Wu FT, Yang YC, Wu CY, Liu MT, Hsiao PW.
    Antiviral Res; 2017 Apr 01; 140():62-75. PubMed ID: 28093338
    [Abstract] [Full Text] [Related]

  • 10. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
    Zost SJ, Lee J, Gumina ME, Parkhouse K, Henry C, Wu NC, Lee CD, Wilson IA, Wilson PC, Bloom JD, Hensley SE.
    Cell Rep; 2019 Dec 24; 29(13):4460-4470.e8. PubMed ID: 31875553
    [Abstract] [Full Text] [Related]

  • 11. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
    Galli C, Orsi A, Pariani E, Lai PL, Guarona G, Pellegrinelli L, Ebranati E, Icardi G, Panatto D.
    Expert Rev Vaccines; 2020 Jan 24; 19(1):115-122. PubMed ID: 31875483
    [Abstract] [Full Text] [Related]

  • 12. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X, Ilyushina NA, Lugovtsev VY, Bovin NV, Couzens LK, Gao J, Donnelly RP, Eichelberger MC, Wan H.
    J Virol; 2017 Jan 15; 91(2):. PubMed ID: 27807224
    [Abstract] [Full Text] [Related]

  • 13. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Wang W, Alvarado-Facundo E, Vassell R, Collins L, Colombo RE, Ganesan A, Geaney C, Hrncir D, Lalani T, Markelz AE, Maves RC, McClenathan B, Mende K, Richard SA, Schofield C, Seshadri S, Spooner C, Utz GC, Warkentien TE, Levine M, Coles CL, Burgess TH, Eichelberger M, Weiss CD.
    Clin Infect Dis; 2021 Dec 06; 73(11):e4312-e4320. PubMed ID: 32898271
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W, Gross FL, Holiday C, Jefferson SN, Bai Y, Liu F, Katz JM, Levine MZ.
    Viral Immunol; 2016 May 06; 29(4):259-62. PubMed ID: 26950058
    [Abstract] [Full Text] [Related]

  • 15. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F, Liu STH, Sun W, Krammer F, Simon V, Palese P.
    J Virol; 2018 Oct 15; 92(20):. PubMed ID: 30045991
    [Abstract] [Full Text] [Related]

  • 16. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
    Gouma S, Weirick M, Hensley SE.
    Nat Commun; 2020 May 15; 11(1):2445. PubMed ID: 32415074
    [Abstract] [Full Text] [Related]

  • 17. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.
    Virology; 2015 Dec 15; 486():134-45. PubMed ID: 26433051
    [Abstract] [Full Text] [Related]

  • 18. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
    Allen JD, Ross TM.
    Hum Vaccin Immunother; 2018 Dec 15; 14(8):1840-1847. PubMed ID: 29641358
    [Abstract] [Full Text] [Related]

  • 19. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ.
    Immunology; 2016 Jun 15; 148(2):160-73. PubMed ID: 26854888
    [Abstract] [Full Text] [Related]

  • 20. Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
    Chong Y, Ikematsu H.
    Hum Vaccin Immunother; 2018 Mar 04; 14(3):518-522. PubMed ID: 28857677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.